Patent Application

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 360 Experts worldwide ranked by ideXlab platform

Berend Jan Bosch - One of the best experts on this subject based on the ideXlab platform.

  • publisher correction a human monoclonal antibody blocking sars cov 2 infection
    Nature Communications, 2020
    Co-Authors: Chunyan Wang, Dubravka Drabek, Nisreen M A Okba, Rien Van Haperen, Albert D M E Osterhaus, Frank J M Van Kuppeveld, Bart L Haagmans, Frank Grosveld, Berend Jan Bosch
    Abstract:

    textabstractThe competing interests section of the original article contained an error. In the sentence “A Patent Application has been filed on 12 March 2020 on monoclonal antibodies targeting SARS-CoV-2 (United Kingdom Patent Application no. 2003632.3”, the number 2003632 was hyperlinked in error to an irrelevant page. The link has been removed both from the PDF and the HTML version of the article.

  • publisher correction a human monoclonal antibody blocking sars cov 2 infection
    Nature Communications, 2020
    Co-Authors: Chunyan Wang, Dubravka Drabek, Nisreen M A Okba, Rien Van Haperen, Albert D M E Osterhaus, Frank J M Van Kuppeveld, Bart L Haagmans, Frank Grosveld, Berend Jan Bosch
    Abstract:

    The competing interests section of the original article contained an error. In the sentence “A Patent Application has been filed on 12 March 2020 on monoclonal antibodies targeting SARS-CoV-2 (United Kingdom Patent Application no. 2003632.3”, the number 2003632 was hyperlinked in error to an irrelevant page. The link has been removed both from the PDF and the HTML version of the article.

Chunyan Wang - One of the best experts on this subject based on the ideXlab platform.

  • publisher correction a human monoclonal antibody blocking sars cov 2 infection
    Nature Communications, 2020
    Co-Authors: Chunyan Wang, Dubravka Drabek, Nisreen M A Okba, Rien Van Haperen, Albert D M E Osterhaus, Frank J M Van Kuppeveld, Bart L Haagmans, Frank Grosveld, Berend Jan Bosch
    Abstract:

    textabstractThe competing interests section of the original article contained an error. In the sentence “A Patent Application has been filed on 12 March 2020 on monoclonal antibodies targeting SARS-CoV-2 (United Kingdom Patent Application no. 2003632.3”, the number 2003632 was hyperlinked in error to an irrelevant page. The link has been removed both from the PDF and the HTML version of the article.

  • publisher correction a human monoclonal antibody blocking sars cov 2 infection
    Nature Communications, 2020
    Co-Authors: Chunyan Wang, Dubravka Drabek, Nisreen M A Okba, Rien Van Haperen, Albert D M E Osterhaus, Frank J M Van Kuppeveld, Bart L Haagmans, Frank Grosveld, Berend Jan Bosch
    Abstract:

    The competing interests section of the original article contained an error. In the sentence “A Patent Application has been filed on 12 March 2020 on monoclonal antibodies targeting SARS-CoV-2 (United Kingdom Patent Application no. 2003632.3”, the number 2003632 was hyperlinked in error to an irrelevant page. The link has been removed both from the PDF and the HTML version of the article.

Nisreen M A Okba - One of the best experts on this subject based on the ideXlab platform.

  • publisher correction a human monoclonal antibody blocking sars cov 2 infection
    Nature Communications, 2020
    Co-Authors: Chunyan Wang, Dubravka Drabek, Nisreen M A Okba, Rien Van Haperen, Albert D M E Osterhaus, Frank J M Van Kuppeveld, Bart L Haagmans, Frank Grosveld, Berend Jan Bosch
    Abstract:

    textabstractThe competing interests section of the original article contained an error. In the sentence “A Patent Application has been filed on 12 March 2020 on monoclonal antibodies targeting SARS-CoV-2 (United Kingdom Patent Application no. 2003632.3”, the number 2003632 was hyperlinked in error to an irrelevant page. The link has been removed both from the PDF and the HTML version of the article.

  • publisher correction a human monoclonal antibody blocking sars cov 2 infection
    Nature Communications, 2020
    Co-Authors: Chunyan Wang, Dubravka Drabek, Nisreen M A Okba, Rien Van Haperen, Albert D M E Osterhaus, Frank J M Van Kuppeveld, Bart L Haagmans, Frank Grosveld, Berend Jan Bosch
    Abstract:

    The competing interests section of the original article contained an error. In the sentence “A Patent Application has been filed on 12 March 2020 on monoclonal antibodies targeting SARS-CoV-2 (United Kingdom Patent Application no. 2003632.3”, the number 2003632 was hyperlinked in error to an irrelevant page. The link has been removed both from the PDF and the HTML version of the article.

Frank Grosveld - One of the best experts on this subject based on the ideXlab platform.

  • publisher correction a human monoclonal antibody blocking sars cov 2 infection
    Nature Communications, 2020
    Co-Authors: Chunyan Wang, Dubravka Drabek, Nisreen M A Okba, Rien Van Haperen, Albert D M E Osterhaus, Frank J M Van Kuppeveld, Bart L Haagmans, Frank Grosveld, Berend Jan Bosch
    Abstract:

    textabstractThe competing interests section of the original article contained an error. In the sentence “A Patent Application has been filed on 12 March 2020 on monoclonal antibodies targeting SARS-CoV-2 (United Kingdom Patent Application no. 2003632.3”, the number 2003632 was hyperlinked in error to an irrelevant page. The link has been removed both from the PDF and the HTML version of the article.

  • publisher correction a human monoclonal antibody blocking sars cov 2 infection
    Nature Communications, 2020
    Co-Authors: Chunyan Wang, Dubravka Drabek, Nisreen M A Okba, Rien Van Haperen, Albert D M E Osterhaus, Frank J M Van Kuppeveld, Bart L Haagmans, Frank Grosveld, Berend Jan Bosch
    Abstract:

    The competing interests section of the original article contained an error. In the sentence “A Patent Application has been filed on 12 March 2020 on monoclonal antibodies targeting SARS-CoV-2 (United Kingdom Patent Application no. 2003632.3”, the number 2003632 was hyperlinked in error to an irrelevant page. The link has been removed both from the PDF and the HTML version of the article.

Bart L Haagmans - One of the best experts on this subject based on the ideXlab platform.

  • publisher correction a human monoclonal antibody blocking sars cov 2 infection
    Nature Communications, 2020
    Co-Authors: Chunyan Wang, Dubravka Drabek, Nisreen M A Okba, Rien Van Haperen, Albert D M E Osterhaus, Frank J M Van Kuppeveld, Bart L Haagmans, Frank Grosveld, Berend Jan Bosch
    Abstract:

    textabstractThe competing interests section of the original article contained an error. In the sentence “A Patent Application has been filed on 12 March 2020 on monoclonal antibodies targeting SARS-CoV-2 (United Kingdom Patent Application no. 2003632.3”, the number 2003632 was hyperlinked in error to an irrelevant page. The link has been removed both from the PDF and the HTML version of the article.

  • publisher correction a human monoclonal antibody blocking sars cov 2 infection
    Nature Communications, 2020
    Co-Authors: Chunyan Wang, Dubravka Drabek, Nisreen M A Okba, Rien Van Haperen, Albert D M E Osterhaus, Frank J M Van Kuppeveld, Bart L Haagmans, Frank Grosveld, Berend Jan Bosch
    Abstract:

    The competing interests section of the original article contained an error. In the sentence “A Patent Application has been filed on 12 March 2020 on monoclonal antibodies targeting SARS-CoV-2 (United Kingdom Patent Application no. 2003632.3”, the number 2003632 was hyperlinked in error to an irrelevant page. The link has been removed both from the PDF and the HTML version of the article.

Patent Application - 15 days free trial to Access Experts & Abstracts